Discover 889 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 889
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
for
Prurigo Nodularis
Location: Birmingham AL, St Louis MO, Indianapolis IN, Dayton OH,
Sponsor: Galderma R&D
Sex: All
Age: 18+
Code: NCT06988618
Recruiting
Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy
for
Chemotherapy Induced Nausea and Vomiting
Location: Mount Olive AL
Sponsor: Simon Williamson Clinic
Sex: All
Age: 18+
Code: NCT06065722
Phase2, Recruiting
New
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
for
Cutaneous Lichen Planus
Location: Birmingham AL, Macon GA, New Orleans LA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07775924
Phase2, Recruiting
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
for
Atrophic Vaginitis, Vaginal Atrophy,
Location: Birmingham AL, West Columbia SC, Fayetteville NC,
Sponsor: Stratpharma AG
Sex: Female
Age: 18+
Code: NCT05953090
Recruiting
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
for
Atopic Dermatitis
Location: Birmingham AL, Greenville SC, North Little Rock AR,
Sponsor: Pfizer
Sex: All
Age: 2 - 11
Code: NCT06807281
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
for
Chronic Inducible Urticaria, Cold Urticaria,
Location: Birmingham AL, Columbus GA, Bowling Green KY,
Sponsor: Celldex Therapeutics
Sex: All
Age: 18+
Code: NCT07266402
Phase3, Recruiting
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for
Overweight, Obesity
Location: Birmingham AL, Cullman AL, Dunwoody GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07282600
Phase3, Recruiting
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age
for
Measles, Measles-Mumps-Rubella+Chickenpox Vaccine
Location: Birmingham AL, Atlanta GA, Simpsonville SC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 1 - 6
Code: NCT07406360
Phase3, Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.